For Research Use Only. MOTS-c is intended strictly for in vitro and preclinical animal research. It is not approved for human use, is not a drug, and should never be administered to humans.
Diet Induced Obesity Research Models
Diet induced obesity is produced in rodent models by feeding a high fat diet over weeks to months. The animals develop excess adiposity, insulin resistance, hepatic steatosis, and the broader metabolic syndrome phenotype that parallels human obesity biology. The model is widely used in metabolic research because it recapitulates many of the pathophysiological features of human obesity while being accessible to defined experimental manipulation. The Nature subject hub on obesity archives primary research on the models and the integrated biology.
Research on MOTS-c in diet induced obesity models documents effects on body weight, body composition, metabolic endpoints, and tissue level markers of obesity pathology. The findings are generally consistent across published studies with the direction of effects favoring reduced adiposity and improved metabolic phenotype under MOTS-c administration.
Body Weight and Body Composition
Published MOTS-c research in diet induced obese rodent models documents body weight reduction during the active treatment period. The magnitude of effect is moderate and depends on the specific rodent model, the duration of treatment, and the dose regimen. The weight reduction is preferentially from fat mass rather than lean mass, which is the desired body composition outcome.
The mechanism of the body weight and composition effects involves multiple pathways. Increased energy expenditure through enhanced mitochondrial function contributes to the energy deficit. Improved substrate utilization including fatty acid oxidation supports the preferential mobilization of adipose stores. Reduced food intake has been documented in some studies but is not a universal finding, suggesting that the effect is primarily on energy expenditure rather than on intake.
The depot specificity of the body composition effect has been examined with variable findings across studies. Some studies report preferential reduction in visceral adipose compared to subcutaneous adipose, similar to the pattern observed with other metabolic interventions covered in the CJC-1295 / Ipamorelin Blend: What Researchers Need to Know and the GLP-1 SM cluster. Other studies report more uniform reduction across depots. The variability may reflect differences in the specific MOTS-c administration protocols and the specific endpoints measured.
Glucose Regulation in Obesity Models
Glucose regulation improves under MOTS-c administration in diet induced obese rodent models. The improvements include reduced fasting glucose, reduced fasting insulin, improved glucose tolerance on glucose challenge testing, and improved insulin sensitivity on insulin challenge testing. The pattern aligns with the effects documented in the insulin sensitivity research article in this cluster.
The glucose regulation improvements reflect the integrated effects across multiple tissues. Skeletal muscle glucose uptake is enhanced through AMPK mediated GLUT4 translocation. Hepatic glucose production is reduced through AMPK mediated suppression of gluconeogenic gene expression. Adipose tissue insulin sensitivity is improved through AMPK activation. The combined effects produce the systemic glucose regulation improvements observed in whole animal research.
Hepatic Steatosis in Obesity Research
Hepatic steatosis is a prominent feature of diet induced obesity and a target for metabolic interventions. Research on MOTS-c effects on hepatic steatosis in obese rodent models documents reductions in hepatic triglyceride content, improvements in liver histology, and favorable changes in hepatic inflammation markers. The magnitude of effect is moderate and is consistent with the indirect mechanisms by which MOTS-c affects hepatic lipid metabolism.
The hepatic effects of MOTS-c are largely indirect because hepatocytes do not express the primary MOTS-c target receptors at high levels. The liver benefits from the systemic improvements in the metabolic environment including reduced adipose lipid supply, improved insulin sensitivity, and reduced inflammatory tone. These indirect effects produce the observed hepatic steatosis reductions.
The Cell Press journal Cell Metabolism and the ScienceDirect hepatic steatosis topic page archive primary research on the integrated biology of metabolic tissue interactions.
Inflammatory Biology in Obesity
Obesity involves chronic low grade inflammation that contributes to many of its downstream metabolic consequences. Adipose tissue inflammation, characterized by macrophage infiltration and pro inflammatory cytokine production, is central to this inflammatory biology. Research on MOTS-c effects on adipose inflammation in obesity models documents reductions in macrophage infiltration markers, shifts in macrophage polarization toward less inflammatory phenotypes, and reductions in circulating inflammatory markers.
The anti inflammatory effects of MOTS-c connect to the broader anti inflammatory research on peptides that affect mitochondrial function. The Wiley Online Library inflammation research collection and the Frontiers in Immunology open access journal both archive primary research on the relationship between mitochondrial biology and inflammation that provides useful context.
Energy Expenditure in Obesity Research
Energy expenditure measurements by indirect calorimetry have been reported in MOTS-c research in obesity models. The findings document modest increases in resting energy expenditure during the active treatment period, with the increase consistent with enhanced mitochondrial function and enhanced substrate oxidation. The magnitude is smaller than what has been reported for dedicated thermogenic interventions but is consistent with the integrated metabolic effects of the peptide.
The energy expenditure findings align with the body composition findings described above. The chronic maintenance of reduced body weight under MOTS-c administration reflects both increased energy expenditure and potentially reduced food intake, with the balance depending on the specific research protocol.